Higher SUA levels were associated with a lower risk for osteoporosis, with sex, race, diabetes status, and serum cholesterol levels identified as potential modifiers.

People who take GLP-1 medications for several years may face a higher risk of developing osteoporosis, gout, and osteomalacia, according to new research presented Monday at the an ...

Recent studies show GLP-1s tied higher osteoporosis risk, with variations by diabetes status and weight changes in large patient datasets.

--Amgen today announced new data from a real-world study of nearly half of a million postmenopausal women with osteoporosis in the U.S. medicare program showing Prolia ® injection reduced fracture ...

At age 48, I underwent a lumpectomy, chemo and radiation for stage I breast cancer. All is good so far, but I started ...

A peer-reviewed study of more than 46,000 older adults with type 2 diabetes found that patients who started GLP-1 receptor agonist drugs faced an 11 percent higher risk of fragility fractures compared ...

A new research study has shed light on potential side effects of GLP-1 drugs, including Wegovy and Ozempic. According to a ...

Many women on dialysis quickly developed severe hypocalcemia after starting denosumab (Prolia) for osteoporosis, Medicare data showed. During the first 12 weeks of treatment, 41.1% of women on ...

People on GLP-1s had slightly higher risks of osteoporosis and gout than similar people not taking these drugs. But diet and ...

Can an augmented health care delivery pathway reduce the chances of those future fractures and improve outcomes that are important to patients? Two University of Alabama at Birmingham researchers have ...